Nanalyze August 19, 2024
Management consultants say that most M&A events don’t realize the synergies penciled on paper prior to the deal being finalized. Only after the transaction do executives find out where the bodies are buried, something that’s sometimes (coincidentally, of course) accompanied by sudden dramatic personnel changes. The whole point of a synergy is that 1 + 1 = 3. So, when a merged company suddenly has two of everything – two CEOs, two CTOs, two CMOs – heads are going to fly, and it’s usually the more dominant company that comes out ahead. Today, we’re going to cover the merger of two AI drug discovery firms – Recursion (RXRX) and Exscientia (EXAI). One we’ve been avoiding, and one we’ve been ogling...
Today's Sponsors
Today's Sponsor